Skip to main content

Advertisement

SpringerLink
Log in

Circadian Disruption, Shift Work and the Risk of Cancer: A Summary of the Evidence and Studies in Seattle

  • Special Section on Cancer and Rhythm
  • Original Paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

There is increasing interest in the possibility that disruption of normal circadian rhythm may increase the risk of developing cancer. Persons who engage in nightshift work may exhibit altered nighttime melatonin levels and reproductive hormone profiles that could increase the risk of hormone-related diseases, including breast cancer. Epidemiologic studies are now beginning to emerge suggesting that women who work at night, and who experience sleep deprivation, circadian disruption, and exposure to light-at-night are at an increased risk of breast cancer, and possibly colorectal cancer as well. Several studies have been conducted in Seattle recently to investigate the effects of factors that can disrupt circadian rhythm and alter normal nocturnal production of melatonin and reproductive hormones of relevance to breast cancer etiology. Studies completed to date have found: (1) an increased risk of breast cancer associated with indicators of exposure to light-at-night and night shift work; and (2) decreased nocturnal urinary levels of 6-sulphatoxymelatonin associated with exposure to 60-Hz magnetic fields in the bedroom the same night, and a number of other factors including hours of daylight, season, alcohol consumption and body mass index. Recently completed is an experimental crossover study designed to investigate whether exposure to a 60-Hz magnetic field under controlled conditions in the home sleeping environment is associated with a decrease in nocturnal urinary concentration of 6-sulphatoxymelatonin, and an increase in the urinary concentration of luteinizing hormone, follicle stimulating hormone, and estradiol in a sample of healthy women of reproductive age. Presently underway is a study to determine whether working at night is associated with decreased levels of urinary 6-sulphatoxymelatonin, and increased urinary concentrations of the reproductive hormones listed above in a sample of healthy women of reproductive age, and to elucidate characteristics of sleep among night shift workers that are related to the hormone patterns identified. A proposal is under review to extend these studies to a sample of healthy men to investigate whether working at night is associated with decreased levels of urinary 6-sulphatoxymelatonin, and increased concentrations of urinary cortisol and cortisone, urinary levels of a number of androgen metabolites, and serum concentrations of a number of reproductive hormones. Secondarily, the proposed study will elucidate characteristics of sleep among night shift workers that are related to the hormone patterns identified, as well as investigate whether polymorphisms of the genes thought to regulate the human circadian clock are associated with the ability to adapt to night shift work. It is anticipated that collectively these studies will enhance our understanding of the role of circadian disruption in the etiology of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Angersbach D, Knauth P, Loskant H, etal. (1980) A retrospective cohort study comparing complaints and diseases in day and shift workers. Intern Arch Occup Environ Health 45:127–140

    CAS  Google Scholar 

  2. Colligan MJ, Frock IJ, Tasto D (1980) Shift work – the incidence of medication use and physical complaints as a function of shift. Occupational and Health Symposia – 1978. Washington, DC: US Dept of Health, Education and Welfare. (NIOSH Publication 80–105)

  3. Minors DS, Scott AR, Waterhouse JM (1986) Circadian arrhythmia: shiftwork, travel and health. J Soc Occup Med 36:39–44

    CAS  PubMed  Google Scholar 

  4. Knutsson A, Hallquist J, Reuterwall C, etal. (1999) Shift work and myocardial infarction: a case–control study. Occup Environ Med 56:46–50

    CAS  PubMed  Google Scholar 

  5. Steenland K, Fine L (1996) Shift work, shift change, and risk of death from heart disease at work. Am J Ind Med 29:278–281

    Article  CAS  PubMed  Google Scholar 

  6. Tuchsen F (1993) Working hours and ischaemic heart disease in Danish men: a 4-year cohort study of hospitalization. Int J Epidemiol 22:215–221

    CAS  PubMed  Google Scholar 

  7. Knutsson A, Akerstedt T, Jonsson BG, etal. (1986) Increased risk of ischaemic heart disease in shift workers. Lancet 2:89–92

    CAS  PubMed  Google Scholar 

  8. Kawachi I, Colditz GA, Stampfer MJ, etal. (1995) Prospective study of shift work and risk of coronary heart disease in women. Circulation 92:3178–3182

    CAS  PubMed  Google Scholar 

  9. Alfredsson L, Karasek R, Theorell T (1982) Myocardial infarction risk and psychosocial work environment: an analysis of the male Swedish working force. Soc Sci Med 16:463–467

    Article  CAS  PubMed  Google Scholar 

  10. Tenkanen L, Sjoblom T, Kalimo R, etal. (1997) Shift work, occupation and coronary heart disease over 6 years of follow-up in the Helsinki Heart Study. Scand J Work Environ Health 23:257–265

    CAS  PubMed  Google Scholar 

  11. Mammalle N, Laumon E, Lazar P (1984) Prematurity and occupational activity during pregnancy. Am J Epidemiol 119:309

    Google Scholar 

  12. McDonald AD, McDonald JC, Armstrong B, etal. (1988) Prematurity and work in pregnancy. Br J Ind Med 45:56–62

    CAS  PubMed  Google Scholar 

  13. Nurminen T (1989) Shift work, fetal development and course of pregnancy. Scand J Work Environ Health 15:395–403

    CAS  PubMed  Google Scholar 

  14. Arendt J, Deacon S (1997) Treatment of circadian rhythm disorders–melatonin. Chronobiol Int 14:185–204

    CAS  PubMed  Google Scholar 

  15. Axelsson G, Rylander R, Molin I (1989) Outcome of pregnancy in relation to irregular and inconvenient work schedules. Br J Ind Med 46:393–398

    CAS  PubMed  Google Scholar 

  16. Xu X, Ding M, Li B, Christiani DC (1994) Association of rotating shiftwork with preterm births and low birth weight among never smoking women textile workers in China. Occup Environ Med 51:470–474

    CAS  PubMed  Google Scholar 

  17. McDonald AD, McDonald JC, Armstrong B, et al. (1988) Fetal death and work in pregnancy. Br J Ind Med 45:148–157

    CAS  PubMed  Google Scholar 

  18. Axelsson G, Ahlborg G Jr, Bodin L (1996) Shift work, nitrous oxide exposure, and spontaneous abortion among Swedish midwives. Occup Environ Med 53:374–378

    CAS  PubMed  Google Scholar 

  19. Axelsson G, Lutz C, Rylander R (1984) Exposure to solvents and outcome of pregnancy in university laboratory employees. Br J Ind Med 41:305–312

    CAS  PubMed  Google Scholar 

  20. Hemminki K, Kyyronen P, Lindbohm ML (1985) Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome. J Epidemiol Community Health 39:141–147

    CAS  PubMed  Google Scholar 

  21. Uehata T, Sasakawa N (1982) The fatigue and maternity disturbances of night workwomen. J Hum Ergol (Tokyo) 11:465–474

    Google Scholar 

  22. Ahlborg G Jr, Axelsson G, Bodin L (1996) Shift work, nitrous oxide exposure and subfertility among Swedish midwives. Int J Epidemiol 25:783–790

    PubMed  Google Scholar 

  23. Bisanti L, Olsen J, Basso O, etal. (1996) Shift work and subfecundity: a European multicenter study. J Occup Environ Med 38:352–358

    CAS  PubMed  Google Scholar 

  24. Hansen J (2001) Increased breast cancer risk among women who work predominantly at night. Epidemiology 12:74–77

    Article  CAS  PubMed  Google Scholar 

  25. Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night, and the risk of breast cancer. J Natl Cancer Inst 93:1557–1562

    CAS  PubMed  Google Scholar 

  26. Schernhammer ES, Laden F, Speizer FE, etal. (2001) Rotating night shifts and risk of breast cancer in women participating in the Nurses’ Health Study. J Natl Cancer Inst 93:1563–1568

    CAS  PubMed  Google Scholar 

  27. Schernhammer ES, Laden F, Speizer FE, etal. (2003) Night-Shift Work and Risk of Colorectal Cancer in the Nurses’ Health Study. J Natl Cancer Inst 95:825–828

    PubMed  Google Scholar 

  28. Pukkala E, Auvinen H, Wahlberg G (1995) Incidence of cancer among Finnish airline cabin attendants. BMJ 311:649–652

    CAS  PubMed  Google Scholar 

  29. Rafnsson V, Tulinius H, Jonasson JG, etal. (2001) Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 12:95–101

    Article  CAS  PubMed  Google Scholar 

  30. Tynes T, Hannevik M, Andersen A, etal. (1996) Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 7:197–204

    Article  CAS  PubMed  Google Scholar 

  31. Band PR, Spinelli JJ, Ng VTY, etal. (1990) Mortality and cancer incidence in a cohort of commercial airline pilots. Aviat Space Environ Med 61:299–302

    CAS  PubMed  Google Scholar 

  32. Irvine D, Davies DM (1992) The mortality of British Airways pilots 1966–89:a proportional mortality study. Aviat Space Environ Med 63:276–279

    CAS  PubMed  Google Scholar 

  33. Band PR, Le ND, Fang R, etal. (1996) Cohort study of Air Canada pilots: mortality, cancer incidence, and leukemia risk. Am J Epidemiol 143:137–143

    CAS  PubMed  Google Scholar 

  34. Krstev S, Baris D, Stewart PA, etal. (1998) Risk for prostate cancer by occupation and industry: a 24-state death certificate study. Am J Ind Med 34:413–420

    CAS  PubMed  Google Scholar 

  35. Irvine D, Davies DM (1999) British Airways flightdeck mortality study, 1950–92. Aviat Space Environ Med 70:548–555

    CAS  PubMed  Google Scholar 

  36. Rfnassan V, Hrafnkelsson J, Tulinius H (2000) Incidence of cancer among commercial airline pilots. Occup Environ Med 57:175–179

    Google Scholar 

  37. Pukkala E, Aspholm R, Auvinen A, etal. (2002) Incidence of cancer among Nordic airline pilots over five decades: occupational cohort study. BMJ 325:567–569

    Article  PubMed  Google Scholar 

  38. Pukkala E, Aspholm R, Auvinen A, etal. (2003) Cancer incidence among 10,211 airline pilots: a Nordic study. Aviat Space Environ Med 74:699–706

    PubMed  Google Scholar 

  39. Krstev S, Baris D, Stewart P, etal. (1998) Occupational risk factors and prostate cancer in U.S. blacks and whites. Am J Ind Med 34:421–430

    CAS  PubMed  Google Scholar 

  40. Demers PA, Checkoway H, Vaughan TL, etal. (1994) Cancer incidence among firefighters in Seattle and Tacoma, Washington (United States). Cancer Causes Control 5:129–135

    Article  CAS  PubMed  Google Scholar 

  41. Hill SM, Blask DE (1988) Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 48:6121–6126

    CAS  PubMed  Google Scholar 

  42. Cos S, Fernandez F, Sanchez-Barcelo EJ (1996) Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro. Life Sci 58:2447–2453

    CAS  PubMed  Google Scholar 

  43. Cos S, Fernandez R, Guezmes A, etal. (1998) Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells.Cancer Res 58:4383–4390

    CAS  PubMed  Google Scholar 

  44. Cos S, Mediavilla MD, Fernandez R, etal. (2002) Does melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro? J Pineal Res 32:90–96

    Article  CAS  PubMed  Google Scholar 

  45. Mediavilla MD, Cos S, Sanchez-Barcelo EJ (1999) Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sci 65:415–420

    Article  CAS  PubMed  Google Scholar 

  46. Siu SW, Lau KW, Tam PC, etal. (2002) Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Prostate 52:106–122

    Article  CAS  PubMed  Google Scholar 

  47. Rimler A, Lupwitz Z, Zisapel N (2002) Differential regulation by melatonin of cell growth and androgen receptor binding to the androgen response element in prostate cancer cells. Neuroendocrinol Lett 23:45–49

    CAS  PubMed  Google Scholar 

  48. Marelli MM, Limonta P, Maggi R, etal. (2000) Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells. Prostate 45:238–244

    Article  CAS  PubMed  Google Scholar 

  49. Xi SC, Tam PC, Brown GM, etal. (2000) Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells. J Pineal Res 29:172–183

    Article  CAS  PubMed  Google Scholar 

  50. Moretti RM, Marelli MM, Maggi R, etal. (2000) Anti-proliferative action of melatonin on human prostate cancer LNCaP cells. Oncol Rep 7:347–351

    CAS  PubMed  Google Scholar 

  51. Philo R, Berkowitz AS (1988) Inhibition of dunning tumor growth by melatonin. J Urol 139:1099–1102

    CAS  PubMed  Google Scholar 

  52. Sze SF, Ng TB, Liu WK (1993) Anti-proliferative effect of pineal indoles on cultured tumor cell lines. J Pineal Res 14:27–33

    CAS  PubMed  Google Scholar 

  53. Ying SW, Niles LP, Crocker C (1993) Human malignant melanoma cells express high-affinity receptors for melatonin: anti-proliferative effects of melatonin and 6-chloromelatonin. Eur J Pharmacol 246:89–96

    CAS  PubMed  Google Scholar 

  54. Petranka J, Baldwin WS, Bierman J, etal. (1999) The oncostatic action of melatonin in an ovarian carcinoma cell line. J Pineal Res 26:129–136

    CAS  PubMed  Google Scholar 

  55. Shiu SY, Li L, Xu JN, etal. (1999) Melatonin-induced inhibition of proliferation and G1/S cell cycle transition delay of human choriocarcinoma JAr cells: possible involvement of MT2 (MEL1B) receptor. J Pineal Res 27:183–192

    CAS  PubMed  Google Scholar 

  56. Kanishi Y, Kobayashi Y, Noda S, etal. (2000) Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines. J Pineal Res 28:227–233

    Article  CAS  PubMed  Google Scholar 

  57. Tamarkin L, Cohen M, Roselle D, etal. (1981) Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res 41:4432–4436

    CAS  PubMed  Google Scholar 

  58. Musatov SA, Anisimov VN, Andre V, etal. (1999) Effects of melatonin on N-nitroso-N-methylurea-induced carcinogenesis in rats and mutagenesis in vitro (Ames test and COMET assay). Cancer Lett 138:37–44

    Article  CAS  PubMed  Google Scholar 

  59. Anisimov VN, Popovich IG, Zabezhinski MA (1997) Melatonin and colon carcinogenesis: I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. Carcinogenesis 18:1549–1553

    Article  CAS  PubMed  Google Scholar 

  60. Anisimov VN, Kvetnoy IM, Chumakova NK, etal. (1999) Melatonin and colon carcinogenesis. Exp Toxicol Pathol 51:47–52

    CAS  PubMed  Google Scholar 

  61. Cini G, Coronnello M, Mini E, etal. (1988) Melatonin’s growth-inhibitory effect on hepatoma AH 130 in the rat. Cancer Lett 125:51–59

    Google Scholar 

  62. Mocchegiani E, Perissin L, Santarelli L, etal. (1999) Melatonin administration in tumor-bearing mice (intact and pinealectomized) in relation to stress, zinc, thymulin and IL-2. Int J Immunopharmacol 21:27–46

    CAS  PubMed  Google Scholar 

  63. Subramanian A, Kothari L (1991) Melatonin, a suppressor of spontaneous murine mammary tumors. J Pineal Res 10(3):136–140

    CAS  PubMed  Google Scholar 

  64. Jochle W (1964) Trends in photophysiologic concepts. Ann N Y Acad Sci 117:88–104

    Google Scholar 

  65. Shah PN, Mhatre MC, Kothari LS (1984) Effect of melatonin on mammary carcinogenesis in intact and pinealectomized rats in varying photoperiods. Cancer Res 44:3403–3407

    CAS  PubMed  Google Scholar 

  66. Blask DE, Sauer LA, Dauchy R, etal. (1999) New actions of melatonin on tumor metabolism and growth. Biol Signals Recept 8:49–55

    CAS  PubMed  Google Scholar 

  67. Blask DE, Dauchy RT, Sauer LA, etal. (2002) Light during darkness, melatonin suppression and cancer progression. Neuroendocrinol Lett 23:52–56

    PubMed  Google Scholar 

  68. Dauchy RT, Sauer LA, Blask DE, etal. (1997) Light contamination during the dark phase in “photoperiodically controlled” animal rooms: effect on tumor growth and metabolism in rats. Lab Anim Sci 47:511–518

    CAS  PubMed  Google Scholar 

  69. Dauchy RT, Blask DE, Sauer LA, etal. (1999) Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett 144:131–136

    Article  CAS  PubMed  Google Scholar 

  70. Hahn RA (1991) Profound bilateral blindness and the incidence of breast cancer. Epidemiology 2:208–210

    CAS  PubMed  Google Scholar 

  71. Feychting M, Osterlund B, Ahlbom A (1998) Reduced cancer incidence among the blind. Epidemiology 9:490–494

    CAS  PubMed  Google Scholar 

  72. Pukkala E, Verkasalo PK, Ojamo M, etal. (1999) Visual impairment and cancer: a population-based cohort study in Finland. Cancer Causes Control 10:13–20

    Article  CAS  PubMed  Google Scholar 

  73. Verkasalo PK, Pukkala E, Stevens RG, etal. (1999) Inverse association between breast cancer incidence and degree of visual impairment in Finland. Br J Cancer 80:1459–1460

    Article  CAS  PubMed  Google Scholar 

  74. Kliukiene J, Tynes T, Andersen A (2001) Risk of breast cancer among Norwegian women with visual impairment. Br J Cancer 84:397–399

    Article  CAS  PubMed  Google Scholar 

  75. Reppert SM, Weaver DR (2001) Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63:647–676

    Article  CAS  PubMed  Google Scholar 

  76. Katzenberg D, Young T, Finn L, etal. (1998) A CLOCK polymorphism associated with human diurnal preference. Sleep 21:569–576

    CAS  PubMed  Google Scholar 

  77. Johansson C, Willeit M, Smedh C, etal. (2003) Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology 28(4):734–739

    Article  CAS  PubMed  Google Scholar 

  78. Archer SN, Robilliard DL, Skene DJ, etal. (2003) A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 26:413–415

    PubMed  Google Scholar 

  79. Ebisawa T, Uchiyama M, Kajimura N, etal. (2001) Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome. EMBO Rep 2:342–346

    Article  CAS  PubMed  Google Scholar 

  80. Parry BL, Newton RP (2001) Chronobiological basis of female-specific mood disorders. Neuropsychopharmacology 25:S102–S108

    Article  CAS  PubMed  Google Scholar 

  81. Zhu Y, Brown HN, Zhang Y, etal. (2005) Period3 structural variation: a circadian biomarker associated with breast cancer in young women. Cancer Epidemiol Biomarkers Prev 14:268–270

    CAS  PubMed  Google Scholar 

  82. Fu L, Pelicano H, Liu J, etal. (2002) The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111:41–50

    CAS  PubMed  Google Scholar 

  83. Davis S, Kaune WT, Mirick D, Chen C, Stevens RG. (2001) Residential Magnetic Fields, Light-at-Night, and Nocturnal Urinary 6-sulphatoxymelatonin in Women. Am J Epidemiol 154:591–600

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Program in Epidemiology, Division of Public Health Sciences Fred Hutchinson Cancer Research Center, Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, 1100 Fairview Avenue North M4-B874, P.O. Box 19024, Seattle, WA, 98109-1024, USA

    Scott Davis

  2. Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

    Scott Davis & Dana K. Mirick

Authors
  1. Scott Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dana K. Mirick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Scott Davis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davis, S., Mirick, D.K. Circadian Disruption, Shift Work and the Risk of Cancer: A Summary of the Evidence and Studies in Seattle. Cancer Causes Control 17, 539–545 (2006). https://doi.org/10.1007/s10552-005-9010-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-005-9010-9

Keywords

Search

Navigation